What does LB Pharmaceuticals Inc do?
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia;…
What is LB Pharmaceuticals Inc's P/E and P/B ratio?
LB Pharmaceuticals Inc has a P/E ratio of 394.2 and a P/B ratio of 3.83.
What is LB Pharmaceuticals Inc's debt-to-equity ratio?
LB Pharmaceuticals Inc has a debt-to-equity ratio of 0.02.
How much does LB Pharmaceuticals Inc owe compared with what it owns?
LB Pharmaceuticals Inc owes $0.08 for every $1 it owns (balance sheet Jun 2026), which is low.
What is LB Pharmaceuticals Inc's Positivity rank?
LB Pharmaceuticals Inc is ranked #4,227 of 6,774 companies globally and #2,060 of 4,000 in United States on PositoAI, with a Positivity Score of 19,757.
Does LB Pharmaceuticals Inc have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for LB Pharmaceuticals Inc.
Where can I read the latest news about LB Pharmaceuticals Inc?
Recent headlines about LB Pharmaceuticals Inc from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does LB Pharmaceuticals Inc have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of LB Pharmaceuticals Inc's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.